CClinicalTrials.gg
TerminatedNCT03779516Updated Apr 30, 2020

Effect of Nebulized Lidocaine on Postoperative Sore Throat

An interventional study of Saline and Lidocaine in Sore Throat, sponsored by Antalya Training and Research Hospital. Terminated at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2020-04-30.

Sponsored by Antalya Training and Research Hospital · Not applicable, Interventional, and Prevention

Why this study was terminated
change in procedure
Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to test the hypothesis that use of preoperative nebulized lidocaine is reduced the incidence of postoperative sore throat after endotracheal intubation.

Read the detailed description

Adult patients undergoing video-assisted thoracic surgery (VATS) requiring double lumen tube (DLT) endotracheal intubation for one-lung ventilation (OLV) were enrolled in the study. Patients were randomized by means of computer-generated order randomization into two groups: Group C (those who received a saline solution as placebo delivered by nebulization) and Group L (those who received lidocaine delivered by nebulization).

At 1, 6 and 24 h after tracheal extubation, an observer blinded to treatments evaluated the patients in terms of sore throat and hoarseness. In addition, Patients' satisfaction, intraoperative and postoperative opioid and analgesics consumption and complaints such as dysphagia, nausea and vomiting were recorded. Hemodynamic variables such as blood pressure and heart rate were also recorded.

02

Conditions studied

  • Sore Throat

Browse trials for

03

In context

Pharyngitis

252 studies on the registry are indexed under Pharyngitis; 35 are open to participants now.

This study's enrollment of 110 is below the median of 145 across 208 interventional studies indexed under Pharyngitis.

Browse Pharyngitis studies →

Lead sponsor

Antalya Training and Research Hospital is the lead sponsor of 102 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients undergoing video-assisted thoracic surgery requiring double lumen tube endotracheal intubation for one-lung ventilation
  • American Society of Anesthesiologists class 1,2 and 3
  • Ability to consent

Exclusion criteria

Exclusion Criteria:

  • patients \<18 years old
  • body mass index (BMI) \<20 or >35 kg/m2
  • Mallampati grade 3 or 4
  • mouth opening \< 3 cm
  • preexisting hoarseness or sore throat
  • coagulopathy
  • patient with upper respiratory tract infection
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
110 participants (actual)

Study arms

  • Active comparator
    Group C

    In Control Group, 4 mL of saline solution was administered using a face mask and a compressed gas-powered jet nebulizer for 15 min

    Other: Saline

  • Active comparator
    Group L

    In Lidocaine Group 4 mL of 4% lidocaine was administered using a face mask and a compressed gas-powered jet nebulizer for 15 min

    Other: Lidocaine

Interventions

  • OtherSaline

    Effect of saline on postoperative sore throat

  • OtherLidocaine

    Effect of nebulized lidocaine on postoperative sore throat

06

What researchers measure

Primary outcomes

  1. Changes in the incidence of postoperative sore throat

    Sore throat was assessed using a 0-100 mm visual analog scale (VAS), where a score of 0 represents no pain and a score of 100 reflects the worst pain imaginable.

    Time frame: 24 hours

Secondary outcomes

  1. whether the hoarseness was present or not

    Hoarseness was defined as a change in voice quality and it was assessed by the patients themselves. The change in voice quality at any time during the observation period was defined as "hoarseness was present".

    Time frame: 24 hours

  2. Intraoperative opioid consumption

    Assessed in intraoperative period

    Time frame: 60 minutes

  3. Postoperative analgesic consumption

    Assessed in postoperative period

    Time frame: 24 hours

  4. Changes in mean arterial pressure

    Assessed every 5 minutes during the procedure

    Time frame: 60 minutes

  5. Changes in heart rate

    Assessed every 5 minutes during the procedure

    Time frame: 60 minutes

07

Study locations

1 site
  • Antalya Training and Research Hospital
    Antalya, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03779516
Lead sponsor
Antalya Training and Research Hospital
Responsible party
Sponsor
First posted
Dec 19, 2018
Start date
Dec 19, 2018
Primary completion
Apr 22, 2019
Completion
Jul 15, 2019
Last update
Apr 30, 2020

Study contacts

Ali Sait Kavakli, MD
principal investigator · Antalya Training and Research Hospital
Hilal Yavuzel, MD
principal investigator · Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Ulku Arslan, MD
principal investigator · Karabuk University Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion